Pharmatica

The Chain Reaction

Science EN ↓ 3 avsnitt

Chain Reaction covers pharmaceutical manufacturing, bioprocessing, scale-up strategy, CDMO partnerships, cold chain logistics, quality assurance, validation, smart factories, supply chain resilience and the operational decisions that move therapies from production to patients.

Glöm inte att besöka poddens webbplats och stötta skaparen: pharmatica.io

Skapare

Pharmatica

Kategori

Science

Poddens webbplats

pharmatica.io

Senaste avsnittet

8 jul 2026

Var kan du lyssna?

Poddar i appen Replaio Radio Kommer snart

Poddar kommer snart till appen. Installera nu och bli först med att uppleva ett helt nytt sätt att lyssna på poddar

Installera gratis Android nästan 10 mn nedladdningar · betyg 4,8 iOS snart

Avsnitt

How AI Is Reshaping Data Integrity in Pharma Manufacturing 08.07.2026 44:01

With artificial intelligence (AI) now in pharmaceutical manufacturing, regulators have begun to pay close attention. In fact, oftentimes, they move forward without waiting for adequate guidelines. In the recent episode of The Chain Reaction podcast, Nour AlSaleh, Founder and CEO of Veragence Pharma Consultancy, sat down with host Shubhangi Dua, Podcast Producer and B2B Journalist at Pharmatica.io...

The Role of Regulatory Leadership in Healthcare 09.06.2026 21:18

Approval alone does not guarantee patient access, and for pharmaceutical leaders, that gap is becoming one of the industry's most pressing challenges. Regulatory strategy can no longer function as a back-end compliance exercise. It now plays a central role in determining how quickly therapies reach patients, how organisations scale across markets, and whether innovation delivers measurable healthc...

Rebuilding Healthcare Supply Chains in Africa: Lessons from COVID-19 and the Road Ahead 09.06.2026 23:57

Healthcare systems around the world are facing growing pressure from supply chain disruption, rising costs, regulatory complexity, and persistent medicine shortages. The COVID-19 pandemic exposed just how vulnerable global pharmaceutical and healthcare networks can be, forcing industry leaders to rethink resilience, localisation, and long-term sustainability. At the same time, emerging technologie...